NBIX (STOCKS)
Neurocrine Biosciences Inc
$126.280000
-11.160000 (-8.12%)
Prev close: $137.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kyle W. Gano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12,257.82M
- Employees
- 1,800
- P/E (TTM)
- 29.43
- P/B (TTM)
- 4.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
12
Strong Buy
18
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.88 | $1.93 | -0.0511 | -2.65% |
|
Sep 2025 (Q3)
|
$2.04 | $1.62 | +0.4223 | +26.11% |
|
Jun 2025 (Q2)
|
$1.06 | $0.99 | +0.0693 | +7.00% |
|
Mar 2025 (Q1)
|
$0.08 | $0.56 | -0.4764 | -85.62% |
Financial Statements
| Assets | $4.27B |
| Current Assets | $2.16B |
| Inventory | $69.30M |
| Prepaid Expenses | $178.10M |
| Other Current Assets | $1.91B |
| Noncurrent Assets | $2.11B |
| Fixed Assets | $97.30M |
| Intangible Assets | $35.70M |
| Other Non-current Assets | $1.97B |
| Liabilities | $1.26B |
| Current Liabilities | $638.00M |
| Wages | $105.10M |
| Other Current Liabilities | $532.90M |
| Noncurrent Liabilities | $624.10M |
| Equity | $3.00B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.00B |
| Liabilities And Equity | $4.27B |